Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q5VZY2
UPID:
PLPP4_HUMAN
Alternative names:
Phosphatidic acid phosphatase type 2 domain-containing protein 1A
Alternative UPACC:
Q5VZY2; A2RU82; Q08EQ2; Q0IIP2; Q495B4; Q5VZY1
Background:
Phospholipid phosphatase 4, also known as Phosphatidic acid phosphatase type 2 domain-containing protein 1A, plays a crucial role in lipid metabolism. It catalyzes the conversion of diacylglycerol pyrophosphate into phosphatidate, impacting both lipid synthesis and the generation of lipid-signaling molecules. This enzyme operates independently of magnesium, showcasing broad substrate specificity.
Therapeutic significance:
Understanding the role of Phospholipid phosphatase 4 could open doors to potential therapeutic strategies. Its involvement in lipid metabolism and signaling pathways presents an opportunity for targeted interventions in metabolic disorders.